Top

6550--Cepheid Testing Kits Notice of Intent to Sole Source

Active

36C25023Q0250Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Department of Veterans Affairs, specifically the VHA Regional Procurement Office Central, Network Contracting Office 10, plans to award a sole source, firm-fixed price purchase order for SARS COVID-2, Flu A&B, and Respiratory Syncytial Virus testing kits to Cepheid for the John D. Dingell VA Medical Center in Detroit, Michigan. The contract is anticipated to cover a two-month period and includes the procurement of 220 boxes of Cepheid XPRESS COV-2/FLU/RSV PLUS testing kits, which are uniquely compatible with the existing Cepheid Multiplex Random Access PCR instrumentation used by the medical center’s clinical microbiology laboratory. This sole source procurement is justified based on Cepheid being the exclusive provider of the proprietary assays needed for the specified instrumentation, ensuring rapid and accurate test results essential for patient care. The solicitation references NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, with a business size standard of 1,250 employees. Although this notice serves to publicize the intent to sole source and is not a request for competitive bids, interested parties may submit statements demonstrating their capability and advantages of competition by the specified deadline. However, the final decision to engage in a competitive process remains at the government’s discretion. All interest and capability responses must be sent to the designated Contract Specialist, Jeffrey Rozema, via email, with no telephone inquiries accepted. This action complies with federal acquisition regulations requiring public notice to inform potential suppliers and ensure transparency in the procurement process.

General Info

VA awards sole source contract to Cepheid for 220 COVID-19, flu, RSV test kits, two months.

Agency

Department Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Set-Aside

NONE

Documents

Cepheid Testing Kits Notice of Intent to Sole Source (36C25023Q0250)

2 pages · sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PostedJan 19

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Contacts1 person available

OfficeDAYTON, OH, 45428, USA

Organization / AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Office AddressDAYTON, OH, 45428, USA

Contacts

Jeffrey RozemaContracting Officer

contact@example.gov

Full Description

INTENT TO SOLE SOURCE The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for SARS COVID 2/Flu A&B/Respiratory Syncytial Virus (RSV) testing kits for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price 2-month purchase order to Cepheid, 904 Caribbean Drive, Sunnyvale, CA 94089. The associated North American Industry Classification System (NAICS) Code is 325413 In-Vitro Diagnostic Substance Manufacturing, and the Business Size Standard is 1,250 Employees. The John D. Dingell VA Medical Center clinical microbiology laboratory offers testing done by molecular protocol which ensures a faster turn-around time as well as very accurate results. This allows the providers a state-of-the-art process to better treat their patients. The laboratory currently owns and utilizes Cepheid Multiplex Random Access PCR Instrumentation. The Cepheid assays for the detection of SAR Covid 2/Flu A&B/RSV are proprietary and specific to this instrumentation. Cepheid has provided supporting documentation stating they are the sole distributor of the testing reagents. The following Cepheid testing kits and estimated 2-month quantities are required: 1) KIT, XPRESS, COV-2/FLU/RSV PLUS, 10 TEST (Catalog Number XP3COV2/FLU/RSV-10), 220 Boxes This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested persons may identify their interests and capability to respond to this requirement no later than 11:59 PM Eastern Time, Monday, January 23, 2023. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Interest/capability statements shall be submitted to Jeffrey Rozema, Contract Specialist, via e-mail at contact@example.gov. Telephone inquiries will not be accepted.